Outset Medical (OM) Net Shares Issued and Repurchased (2020 - 2025)

Outset Medical (OM) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $11000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased fell 97.7% year-over-year to $11000.0 in Q4 2025; TTM through Dec 2025 was $11000.0, a 97.7% decrease from a year earlier, with the FY2025 full-year figure at $11000.0, down 97.7% from the prior year.
• Net Shares Issued and Repurchased was $11000.0 for Q4 2025 at Outset Medical, down from $478000.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $634000.0 in Q4 2021 and troughed at $82.0 in Q4 2023.
• A 5-year average of $224644.8 and a median of $11000.0 in 2025 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased sank 99.98% in 2022 and jumped 582826.83% in 2024, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $634000.0 in 2021, then slumped by 99.98% to $142.0 in 2022, then slumped by 42.25% to $82.0 in 2023, then jumped by 582826.83% to $478000.0 in 2024, then slumped by 97.7% to $11000.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $11000.0 (Q4 2025), $478000.0 (Q4 2024), and $82.0 (Q4 2023), per Business Quant data.